Page 20 - CnO_228

d al c onsiglio d irettiv o
conclusioni
La sensibilità dei cardiologi verso
ASCVD indotta dal diabete è
elevata. La survey mostra infatti
che molti cardiologi effettuano
uno screening ed un monitoraggio
adeguato dei pazienti diabetici
durante un ricovero e la maggior
parte ne stratifica il rischio CV.
Il cardiologo appare abbastanza
autonomo nella gestione del
paziente diabetico con SCA durante
la fase acuta, mentre preferisce,
nella maggior parte dei casi,
interagire con il diabetologo per
la gestione del paziente diabetico
in post-dimissione. Non è ancora
ottimale il livello di conoscenza e
consapevolezza delle potenzialità
dei nuovi farmaci antidiabetici
sul sistema CV. Sono auspicabili
iniziative per promuovere una
maggior e più approfondita
conoscenza delle nuove classi di
antidiabetici innovativi. ♥
Bibliografia
1. Low Wang CC, Hess CN, Hiatt
WR, Goldfine AB. Clinical Update:
Cardiovascular Disease in Diabetes
Mellitus: Atherosclerotic Cardiovascular
Disease and Heart Failure in Type
2 Diabetes Mellitus - Mechanisms,
Management, and Clinical
Considerations. Circulation. 2016 Jun
14;133(24):2459-502.
2. Haffner SM, Lehto S, Rönnemaa T,
Pyörälä K, Laakso M. Mortality from
coronary heart disease in subjects with
type 2 diabetes and in nondiabetic
subjects with and without prior
myocardial infarction. N Engl J Med.
1998 Jul 23;339(4):229-34.
3. Rana JS, Liu JY, Moffet HH, Jaffe M,
Karter AJ. Diabetes and Prior Coronary
18 | cardiologia negli ospedali | duecentoventotto
Heart Disease are Not Necessarily Risk coronary plaque burden by computed
Equivalent for Future Coronary Heart tomography in patients with and
without diabetes mellitus. Eur Radiol.
Disease Events. J Gen Intern Med. 2016
Apr;31(4):387-93. 2011 May;21(5):944-53.
4. Bell DS. Heart failure: the frequent, 11. Edsfeldt A, Gonçalves I, Grufman
H, Nitulescu M, Dunér P, Bengtsson E,
forgotten, and often fatal complication
of diabetes. Diabetes Care. 2003 Mollet IG, Persson A, Nilsson M, Orho-
Aug;26(8):2433-41. Melander M, Melander O, Björkbacka
5. Rao Kondapally Seshasai S, Kaptoge
H, Nilsson J. Impaired fibrous repair: a
S, Thompson A, Di Angelantonio possible contributor to atherosclerotic
E, Gao P, Sarwar N, Whincup PH, plaque vulnerability in patients with
type II diabetes. Arterioscler Thromb
Mukamal KJ, Gillum RF, Holme I,
Njølstad I, Fletcher A, Nilsson P, Vasc Biol. 2014 Sep;34(9):2143-50.
Lewington S, Collins R, Gudnason V, 12. Ferreiro JL, Angiolillo DJ. Diabetes
Thompson SG, Sattar N, Selvin E, Hu
and antiplatelet therapy in acute
FB, Danesh J; Emerging Risk Factors coronary syndrome. Circulation. 2011
Collaboration. Diabetes mellitus, fasting Feb 22;123(7):798-813.
glucose, and risk of cause-specific death. 13. De Luca G, Dirksen MT, Spaulding
C, Kelbæk H, Schalij M, Thuesen L,
N Engl J Med. 2011 Mar 3;364(9):829-
841. van der Hoeven B, Vink MA, Kaiser C,
6. Wong ND. Epidemiological studies Musto C, Chechi T, Spaziani G, Diaz
de la Llera LS, Pasceri V, Di Lorenzo
of CHD and the evolution of preventive
cardiology. Nat Rev Cardiol. 2014 E, Violini R, Suryapranata H, Stone
May;11(5):276-89. GW; DESERT cooperation. Impact of
diabetes on long-term outcome after
7. Wiviott SD, Raz I, Bonaca MP,
Mosenzon O, Kato ET, Cahn A, primary angioplasty: insights from the
Silverman MG, Zelniker TA, Kuder DESERT cooperation. Diabetes Care.
2013 Apr;36(4):1020-5.
JF, Murphy SA, Bhatt DL, Leiter LA,
McGuire DK, Wilding JPH, Ruff CT, 14. Radke PW, Schunkert H. Diabetics
Gause-Nilsson IAM, Fredriksson M, with acute coronary syndrome:
Johansson PA, Langkilde AM, Sabatine advances, challenges, and uncertainties.
MS; DECLARE–TIMI 58 Investigators.
Eur Heart J. 2010 Dec;31(24):2971-3.
Dapagliflozin and Cardiovascular 15. Silverman MG, Blaha MJ, Budoff
Outcomes in Type 2 Diabetes. N Engl J MJ, Rivera JJ, Raggi P, Shaw LJ, Berman
Med. 2019 Jan 24;380(4):347-357.
D, Callister T, Rumberger JA, Rana
8. Mondesir FL, Brown TM, Muntner JS, Blumenthal RS, Nasir K. Potential
P, Durant RW, Carson AP, Safford Implications of Coronary Artery
MM, Levitan EB. Diabetes, diabetes Calcium Testing for Guiding Aspirin
severity, and coronary heart disease risk Use Among Asymptomatic Individuals
equivalence: REasons for Geographic With Diabetes. Diabetes Care 2012 Mar;
and Racial Differences in Stroke 35(3): 624-626. 2017
(REGARDS). Am Heart J. 2016 16. Whelton PK, Carey RM, Aronow
Nov;181:43-51. WS, Casey DE Jr, Collins KJ, Dennison
9. Norhammar A, Malmberg K, Himmelfarb C, DePalma SM, Gidding S,
Diderholm E, Lagerqvist B, Lindahl Jamerson KA, Jones DW, MacLaughlin
B, Rydén L, Wallentin L. Diabetes EJ, Muntner P, Ovbiagele B, Smith SC
mellitus: the major risk factor in Jr, Spencer CC, Stafford RS, Taler SJ,
unstable coronary artery disease even Thomas RJ, Williams KA Sr, Williamson
after consideration of the extent of JD, Wright JT Jr. 2017 ACC/AHA/
coronary artery disease and benefits of AAPA/ABC/ACPM/AGS/APhA/ASH/
revascularization. J Am Coll Cardiol. ASPC/NMA/PCNA Guideline for the
2004 Feb 18;43(4):585-91. Prevention, Detection, Evaluation, and
10. Maffei E, Seitun S, Nieman K, Management of High Blood Pressure
Martini C, Guaricci AI, Tedeschi C, in Adults: A Report of the American
Weustink AC, Mollet NR, Berti E, Grilli College of Cardiology/American Heart
R, Messalli G, Cademartiri F. Assessment Association Task Force on Clinical
of coronary artery disease and calcified Practice Guidelines. Circulation. 2018